We are seeing a surge in investor interest in companies that perform well on environmental and social impact (“ESG” criteria). By 2025, ESG funds will reach $53 trillion, or one third of all assets under management, driven by the global climate and inequity emergencies, and the opportunities these needs represent for business.
Leading companies are setting ambitious ESG targets, yet struggle to meet them when they continue to position “sustainability” as an after-thought, a retro-active risk management remedy for the consequences of strategic and capital allocation decisions made only with a financial lens. That is a vast lost opportunity to win in the emerging green and just economic transition underway globally.
In our article The Essential Link Between ESG Targets and Financial Performance in Harvard Business Review, FSG’s co-founder Mark Kramer and managing director Marc Pfitzer describe why doing the math on the “impact-intensity of profit” is necessary to surface opportunities and constraints to meeting both financial and ESG targets and opens the way to exploring business model and ecosystem transformation that will out-compete in the todays’ economy.
If business could stimulate social progress in every region of the globe, poverty, pollution, and disease would decline and…
With increasing recognition that markets today create wealth and positive social impact inequitably and deplete or degrade natural resources,…
A new purpose-led economy is in the making, with purpose anchored in corporate statutes, board and leadership accountability, and…
FSG brings companies, investors, funders, and governments together to develop strategies to scale inclusive business models, and conducts and…
FSG hosted a session on the Economics of Impact at the Building Bridges Week 2021 in Geneva. Our esteemed…
How much does true change cost? Who is best placed to invest? What are the win-wins and trade-offs? Economics…
Marc is a managing director at FSG. He is co-author of several articles on shared value and the economics…
Sebastien has extensive experience in the health care industry as a former physician, consultant, and private equity investor.
Flynn works with corporate clients on projects in the areas of shared value, global health, and global development. She…
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |